<DOC>
	<DOCNO>NCT03000127</DOCNO>
	<brief_summary>Fatigue major symptom people multiple sclerosis ( MS ) , treatment limit . Several study show large proportion men MS low testosterone level . We propose two-site clinical trial use topical testosterone gel treatment MS-related fatigue men progressive MS low low-normal testosterone level .</brief_summary>
	<brief_title>Testosterone Fatigue Men With MS</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>1 ) Men SPMS PPMS , 2 ) 1860 year old , 3 ) EDSS 1.0 6.5 , 4 ) Low lownormal T &lt; 499ng/dL 5 ) FSS score &gt; 3.6 . 1 ) Prostate specific antigen &gt; 2.5 ( &lt; 49yr age ) &gt; 3.5 ( age &gt; 50yr age ) , 2 ) baseline hematocrit great upper limit normal laboratory use , 3 ) EKG ischemic change , 4 ) history myocardial infarction , unstable angina , stroke , transient ischemic attack , deep vein thrombosis , 5 ) history prostate breast cancer , 6 ) screen T level &gt; 500ng/dL , 7 ) diabetes require treatment , 8 ) current drug/alcohol abuse , 9 ) disease MS cause fatigue , obstructive sleep apnea sleep disorder , untreated thyroid dysfunction , 10 ) RRMS , 11 ) Beck Depression InventoryII ( BDI ) score 20 , 12 ) cognitive dysfunction subject perform study test , 13 ) inability undergo MRI , 14 ) current expect use amphetamine , 15 ) anticipate change medical treatment might affect fatigue score ( e.g. , expect change spasticity , sleep , depression medication ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>testosterone</keyword>
	<keyword>multiple sclerosis</keyword>
	<keyword>fatigue</keyword>
</DOC>